Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02796313 · ClinicalTrials.gov registry record · NA
Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities
A NA study, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT02796313: Completed NA study, sponsored by Washington State University.
NCT02796313 is a NA study that has completed, run by Washington State University. The registered enrollment target is 315 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02796313, a NA study, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
We will conduct a randomized trial to test our DASH (Dietary Approaches to Stop Hypertension) based intervention in 370 adult American Indians with inadequately controlled systolic blood pressure (≥130 mmHg). Over the 5 years of the project, we will recruit and randomize 200 participants from each of 4 urban sites: two in Washington, one in Oklahoma, and one in South Dakota.
Primary Outcome
Systolic blood pressure measurements collected throughout the study.
Interventions
- BEHAVIORAL DASH Groceries + Weekly Sessions
- BEHAVIORAL Groceries + Brochure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2017-11-17 |
| Est. Completion | 2023-03-04 |
| Phase | NA |
What the finished NCT02796313 record still lists
NCT02796313 is an interventional study that assigns participants to a tested intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 2 interventions - of which DASH Groceries + Weekly Sessions is the first listed.
NCT02796313 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02796313 about?
NCT02796313 is a clinical study titled "Diet Intervention for Hypertension: Adaptation and Dissemination to Native Communities". We will conduct a randomized trial to test our DASH (Dietary Approaches to Stop Hypertension) based intervention in 370 adult American Indians with inadequately controlled systolic blood pressure (≥130 mmHg). Over the 5 years of the project, we will recruit and randomize 200 participants from each o...
What is the current status of trial NCT02796313?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2017-11-17. Estimated completion is 2023-03-04.
What interventions are being tested in trial NCT02796313?
The interventions under investigation include: DASH Groceries + Weekly Sessions (BEHAVIORAL), Groceries + Brochure (BEHAVIORAL).
Who is sponsoring clinical trial NCT02796313?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02796313's enrollment target sits among peer trials
315 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI